Background : Clinical trial designs have historically been biased towards the Caucasian population, with limited representation of minorities due to factors such as financial barriers, inequity, and accessibility. This lack of diversity has resulted in the development of drugs that may not be effective or safe for underrepresented populations, thereby posing risks to minority health. This research aims to transform the clinical trial process by identifying innovative strategies to increase diversity, ensuring that clinical trials more accurately reflect the natural epidemiology of diseases, and ultimately driving improved drug development outcomes for all populations. Method : A three-stage study was conducted with distinct participant groups. Stage 1 (Group A) involved a 90-minute Zoom focus group with 19 biopharmaceutical professionals. Stage 2 (Group B) consisted of one-hour individual interviews with 10 patients or healthcare providers to explore their experiences and views on trial diversity. Stage 3 (Group C) used a survey of 305 diverse participants to validate and expand the findings. Results : Barriers to diversity in clinical trials that were identified include a lack of trust, limited access to trial facilities, socioeconomic challenges, ineffective recruitment strategies, and a shortage of culturally competent healthcare providers. Proposed solutions include transforming the trial process through regional trial hubs to enhance access, implementing culturally tailored recruitment strategies, and using telemedicine to reduce participant burden. Additionally, updating the DIVERSE Trials Act, implementing federal protections for clinical trial participants—similar to those provided for jury duty—and promoting transparency through community engagement can help rebuild trust and improve diversity in trial participation. Conclusion : This study demonstrates the significant impact of a lack of diversity in clinical trials on both drug development and health equity, emphasizing how disparities in patient access hinder the inclusivity of clinical research. By exploring how the clinical trial process can be transformed to increase diversity and access, the study offers practical, actionable solutions, including targeted recruitment strategies, regional trial hubs, and culturally tailored outreach. Additionally, it illustrates how diversity in the patient population enhances the drug development process, ensuring clinical trials better reflect the natural epidemiology of the disease and improve the safety and efficacy of treatments. Through its interdisciplinary approach, grounded in complementary theories, this study provides valuable insights and significantly contributes to the literature, offering a roadmap for improving inclusivity in clinical trials and advancing health equity.
KeywordsDiversity
Gray, S. (2021) Diversity in Clinical Trials: Going beyond Why to How. The Association of Clinical Research Professionals. https://acrpnet.org/2021/04/20/diversity-in-clinical-trials-going-beyond-why-to-how/
U.S. Food and Drug Administration (2020) 2020 Drug Trials Snapshots Summary Report. FDA. https://www.fda.gov/media/145718/download
Clark, L.T., Watkins, L., Piña, I.L., Elmer, M., Akinboboye, O., Gorham, M., et al . (2019) Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Current Problems in Cardiology , 44, 148-172. https://doi.org/10.1016/j.cpcardiol.2018.11.002
Stronks, K., Wieringa, N.F. and Hardon, A. (2013) Confronting Diversity in the Production of Clinical Evidence Goes beyond Merely Including Under-Represented Groups in Clinical Trials. Trials , 14, Article No. 177. https://doi.org/10.1186/1745-6215-14-177
Mega, J.L., Close, S.L., Wiviott, S.D., Shen, L., Walker, J.R., Simon, T., et al . (2010) Genetic Variants in ABCB1 and CYP2C19 and Cardiovascular Outcomes after Treatment with Clopidogrel and Prasugrel in the TRITON-TIMI 38 Trial: A Pharmacogenetic Analysis. The Lancet , 376, 1312-1319. https://doi.org/10.1016/s0140-6736(10)61273-1
Chung, W., Hung, S., Hong, H., Hsih, M., Yang, L., Ho, H., et al . (2004) A Marker for Stevens-Johnson Syndrome. Nature , 428, 486. https://doi.org/10.1038/428486a
Fejerman, L., Ahmadiyeh, N., Hu, D., Huntsman, S., Beckman, K.B., Caswell, J.L., et al . (2014) Genome-Wide Association Study of Breast Cancer in Latinas Identifies Novel Protective Variants on 6q25. Nature Communications , 5, Article No. 5260. https://doi.org/10.1038/ncomms6260
Ramamoorthy, A., Pacanowski, M., Bull, J. and Zhang, L. (2015) Racial/Ethnic Differences in Drug Disposition and Response: Review of Recently Approved Drugs. Clinical Pharmacology & Therapeutics , 97, 263-273. https://doi.org/10.1002/cpt.61
Stern, J., Pier, J. and Litonjua, A.A. (2020) Asthma Epidemiology and Risk Factors. Seminars in Immunopathology , 42, 5-15. https://doi.org/10.1007/s00281-020-00785-1
American College of Physicians (2008) Achieving a High-Performance Health Care System with Universal Access: What the United States Can Learn from Other Countries. Annals of Internal Medicine , 148, 55-75. https://doi.org/10.7326/0003-4819-148-1-200801010-00196
Asthma and Allergy Foundation of America (AAFA) (2022) Provides Data on Asthma Prevalence and Disparities in the United States. Asthma and Allergy Foundation of America. https://www.aafa.org
Health Equity
Clinical Trials
Drug Development
Clinical Trial Access
Australian Institute of Health and Welfare (AIHW) (2022) Asthma Statistics in Australia. Australian Institute of Health and Welfare. https://www.aihw.gov.au
Centers for Disease Control and Prevention (CDC) (2022) Asthma Data Across Various Regions and Groups. CDC. https://www.cdc.gov/asthma
Mortimer, K., Lesosky, M., García-Marcos, L., Asher, M.I., Pearce, N., Ellwood, E., et al. (2022) The Burden of Asthma, Hay Fever and Eczema in Adults in 17 Countries: GAN Phase I Study. European Respiratory Journal , 60, Article 2102865. https://doi.org/10.1183/13993003.02865-2021 https://pubmed.ncbi.nlm.nih.gov/35210319/
Global Asthma Network (2022) Comprehensive Global Data on Asthma Prevalence and Management. Global Asthma Report. https://globalasthmanetwork.org
Global Initiative for Asthma (GINA) (2022) Guidelines and Reports on Global Asthma Prevalence and Management. Global Initiative for Asthma. https://ginasthma.org
World Health Organization (WHO) (2022) Global Asthma Mortality and Morbidity Data. World Health Organization. https://www.who.int
Kraschel, K.L. and Roberts, W.J. (2014) Reflecting America’s Patient Population—The Need for Diversity in Clinical Trials. AHLA Connections.
Woods-Burnham, L., Johnson, J.R., Hooker, S.E., Bedell, F.W., Dorff, T.B. and Kittles, R.A. (2021) The Role of Diverse Populations in US Clinical Trials. Med , 2, 21-24. https://doi.org/10.1016/j.medj.2020.12.009
Stewart, J., Krows, M.L., Schaafsma, T.T., Heller, K.B., Brown, E.R., Boonyaratanakornkit, J., et al . (2022) Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials. JAMA Network Open , 5, e2148325. https://doi.org/10.1001/jamanetworkopen.2021.48325
Purnell, T.S., Calhoun, E.A., Golden, S.H., Halladay, J.R., Krok-Schoen, J.L., Appelhans, B.M., et al . (2016) Achieving Health Equity: Closing the Gaps in Health Care Disparities, Interventions, and Research. Health Affairs , 35, 1410-1415. https://doi.org/10.1377/hlthaff.2016.0158
Pettigrew, A.M. (1987) Context and Action in the Transformation of the Firm. Journal of Management Studies , 24, 649-670. https://doi.org/10.1111/j.1467-6486.1987.tb00467.x
Pettigrew, A.M. (1990) Longitudinal Field Research on Change: Theory and Practice. Organization Science , 1, 267-292. https://doi.org/10.1287/orsc.1.3.267
Romanow, D., Cho, S. and Straub, D.W. (2012) Editor’s Comments: Riding the Wave: Past Trends and Future Directions for Health IT Research. MIS Quarterly , 36, 3-5. https://doi.org/10.2307/41703474
Bleady, A., Hafiez, A. and Balal, S. (2018) Dynamic Capabilities Theory: Pinning down a Shifting Concept. Academy of Accounting and Financial Studies Journal , 22, 1-17. https://www.researchgate.net/publication/325257001_Dynamic_capabilities_theory_Pinning_down_a_shifting_concept
Barney, J. (1991) Firm Resources and Sustained Competitive Advantage. Journal of Management , 17, 99-120. https://doi.org/10.1177/014920639101700108
McGrath, R.G. (2013.) The End of Competitive Advantage: How to Keep Your Strategy Moving as Fast as Your Business. Harvard Business Review Press.
Agwunobi, A. and Osborne, P. (2016) Dynamic Capabilities and Healthcare: A Framework for Enhancing the Competitive Advantage of Hospitals. California Management Review , 58, 141-161. https://doi.org/10.1525/cmr.2016.58.4.141
Evans, S., Vladimirova, D., Holgado, M., Van Fossen, K., Yang, M., Silva, E.A., et al . (2017) Business Model Innovation for Sustainability: Towards a Unified Perspective for Creation of Sustainable Business Models. Business Strategy and the Environment , 26, 597-608. https://doi.org/10.1002/bse.1939
17th Congress Diverse Trials Act (2021-2022). https://www.congress.gov/bill/117th-congress/senate-bill/2706
Hwang, T.J. and Brawley, O.W. (2022) New Federal Incentives for Diversity in Clinical Trials. New England Journal of Medicine , 387, 1347-1349. https://doi.org/10.1056/nejmp2209043
Lai, G.Y., Gary, T.L., Tilburt, J., Bolen, S., Baffi, C., Wilson, R.F., et al . (2006) Effectiveness of Strategies to Recruit Underrepresented Populations into Cancer Clinical Trials. Clinical Trials , 3, 133-141. https://doi.org/10.1191/1740774506cn143oa
UyBico, S.J., Pavel, S. and Gross, C.P. (2007) Recruiting Vulnerable Populations into Research: A Systematic Review of Recruitment Interventions. Journal of General Internal Medicine , 22, 852-863. https://doi.org/10.1007/s11606-007-0126-3
El Hazzouri, M. and Hamilton, L.K. (2019) Why Us?! How Members of Minority Groups React to Public Health Advertisements Featuring Their Own Group. Journal of Public Policy & Marketing , 38, 372-390. https://doi.org/10.1177/0743915619846555
Ponelis. S.R. (2015) Using Interpretive Qualitative Case Studies for Exploratory Research in Doctoral Studies: A Case of Information Systems Research in Small and Medium Enterprises. International Journal of Doctoral Studies , 10, 535-550. https://doi.org/10.28945/2339
Stevens, L. and Wrenn, C. (2013) Exploratory (Qualitative) Research. Concise Encyclopedia of Church and Religious Organization Marketing, 53.
Creswell, J.W. and Creswell, J.D. (2005) Mixed Methods Research: Developments, Debates, and Dilemmas. Research in Organizations : Foundations and Methods of Inquiry , 2, 315-326.
Yin, R.K. (2015) Qualitative Research from Start to Finish. Guilford Publications.
Yin, R.K. (1992) The Case Study Method as a Tool for Doing Evaluation. Current Sociology , 40, 121-137. https://doi.org/10.1177/001139292040001009
Janesick, V.J. (1994) The Dance of Qualitative Research Design: Metaphor, Methodology, and Meaning. In: Denzin, N.K. and Lincoln, Y.S., Eds., Handbook of Qualitative Research , Sage Publications, Inc., 209-219.